LDHA-IN-3
Names
[ CAS No. ]:
227010-33-5
[ Name ]:
LDHA-IN-3
Biological Activity
[Description]:
LDHA-IN-3, as a selenobenzene compound, is a potent, noncompetitive lactate dehydrogenase (LDHA) inhibitor (IC50=145.2 nM). LDHA-IN-3 can be used for the research of cancer[1].
[Related Catalog]:
[Target]
IC50: 145.2 nM (LDHA)[1]
[In Vitro]
PSTMB (0~500 μM; 48 hours; MCF-7 cells) shows cytotoxic effect[1]. PSTMB (0.01~1 μM) shows dose-dependent inhibition of LDHA activity. PSTMB (0~0.5 μM) inhibits LDHA activity in Michaelis-Menten and Lineweaver-Burk plots. PSTMB (30 and 50 μM; HT29 cells) induces ROS production and mitochondrial damage[1]. PSTMB can bind to LDHA protein efficiently. PSTMB induces the intrinsic pathway-mediated apoptosis of cancer cells via production of mitochondrial ROS[1]. Cell Viability Assay[1] Cell Line: MCF-7 cells Concentration: 0~500 μM Incubation Time: 48 hours Result: Showed cytotoxic effect.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C13H9F3Se
[ Molecular Weight ]:
301.17